Use of corticotropin releasing factor antagonists and related compositions
US6589947B1 · kind B1 · utility
21Cited by
1References
6Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Oct 26, 2000 |
| Grant date | Jul 8, 2003 |
| Priority date | — |
| Expiry date | Oct 26, 2020 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P9/12
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to compositions and methods of achieving a therapeutic effect including, the treatment or prevention of Syndrome X in an animal, preferably a mammal including a human subject or a companion animal, using a corticotropin releasing factor (CRF) antagonist alone or together with a glucocorticoid receptor antagonist.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.